The higher dose led to a trend of more effective reduction of plasma transthyretin than the lower dose at 6 and 8 weeks after treatment, although the differences did not reach statistical significance.
← all excerpts
Noncanonical target-strand cytosine base editing via engineered Un1Cas12f1 platform.
1
—
—